Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Histocompatibility and liver transplantation

S J Knechtle1, M Kalayolu, A M D'Alessandro

  • 1Department of Surgery, University of Wisconsin Hospital, Madison 53792.

Surgery
|October 1, 1993
PubMed
Summary

Human leukocyte antigen (HLA) class I compatibility improves liver transplant outcomes. Better HLA matching enhances patient and graft survival, contrasting with kidney transplant findings where class II matching is key.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AmAMP1 from Acropora millepora and damicornin define a family of coral-specific antimicrobial peptides related to the Shk toxins of sea anemones.

Developmental and comparative immunology·2020
Same author

Patients' experiences of Parkinson's disease: a qualitative study in glucocerebrosidase and idiopathic Parkinson's disease.

Journal of patient-reported outcomes·2020
Same author

Need for improved public health protection of young people wanting body piercing: evidence from a look-back exercise at a piercing and tattooing premises with poor hygiene practices, Wales (UK) 2015.

Epidemiology and infection·2018
Same author

Control of a community outbreak of hepatitis A in an area of low endemicity, Wales, 2016.

Human vaccines & immunotherapeutics·2017
Same author

Predicting Donor Death: Early Changes in Oxygen Saturation After Withdrawal of Support Predict Successful Donation During Donation After Circulatory Death.

Transplantation proceedings·2016
Same author

Does DCD Donor Time-to-Death Affect Recipient Outcomes? Implications of Time-to-Death at a High-Volume Center in the United States.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016

Area of Science:

  • Transplantation immunology
  • Organ transplantation research
  • Immunogenetics

Background:

  • The impact of donor-recipient histocompatibility on liver transplant rejection remains incompletely understood due to limited data.
  • This study investigates the influence of human leukocyte antigen (HLA) type on immunologic graft loss in primary liver transplantations.

Purpose of the Study:

  • To determine the association between HLA antigen matching and immunologic graft loss in liver transplant recipients.
  • To evaluate the effect of HLA compatibility on patient and graft survival after liver transplantation.

Main Methods:

  • Analysis of 205 primary liver transplantations with HLA A, B, and DR matching data, and 31 with HLA A and B matching.
  • Immunologic graft loss defined as death, retransplantation due to rejection, or graft loss from hepatic artery thrombosis or severe rejection requiring immunosuppression rescue.

Related Experiment Videos

Main Results:

  • A mismatch in HLA class I antigens (A and B) significantly predicted immunologic graft loss (p = 0.018).
  • HLA A mismatch showed a significant correlation with graft loss (p = 0.02), whereas HLA B mismatch did not (p = 0.17).
  • Improved HLA matching was associated with significantly better patient survival (p = 0.02) and overall graft survival (p = 0.009).

Conclusions:

  • HLA class I antigen compatibility positively impacts liver transplant outcomes.
  • These findings suggest that immunologic mechanisms of hepatic allograft rejection may differ from those in kidney transplantation, where class II matching is more critical.